Abstract
The differentiation of early B cell progenitors is controlled by multiple transcriptional regulators and growth-factor receptors. The triad of DNA-binding proteins, E2A, EBF1, and PAX5 is critical for both the early specification and commitment of B cell progenitors, while a larger number of secondary determinants, such as members of the Ikaros, ETS, Runx, and IRF families have more direct roles in promoting stage-specific pre-B gene-expression program. Importantly, it is now apparent that mutations in many of these transcription factors are associated with the progression to acute lymphoblastic leukemia. In this review, we focus on recent studies that have shed light on the transcriptional hierarchy that controls efficient B cell commitment and differentiation as well as focus on the oncogenic consequences of the loss of many of the same factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acquaviva J, Chen X, Ren R (2008) IRF-4 functions as a tumor suppressor in early B-cell development. Blood 112(9):3798–3806. doi:10.1182/blood-2007-10-117838
Adamaki M, Lambrou GI, Athanasiadou A, Tzanoudaki M, Vlahopoulos S, Moschovi M (2013) Implication of IRF4 aberrant gene expression in the acute leukemias of childhood. PLoS ONE 8(8):e72326. doi:10.1371/journal.pone.0072326
Adolfsson J, Borge OJ, Bryder D, Theilgaard-Monch K, Astrand-Grundstrom I, Sitnicka E, Sasaki Y, Jacobsen SE (2001) Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15(4):659–669
Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA, Anderson K, Sitnicka E, Sasaki Y, Sigvardsson M, Jacobsen SE (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121(2):295–306. doi:10.1016/j.cell.2005.02.013
Amin RH, Schlissel MS (2008) Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9(6):613–622. doi:10.1038/ni.1612
Anderson KL, Nelson SL, Perkin HB, Smith KA, Klemsz MJ, Torbett BE (2001) PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J Biol Chem 276(10):7637–7642. doi:10.1074/jbc.M009133200
Back J, Allman D, Chan S, Kastner P (2005) Visualizing PU.1 activity during hematopoiesis. Exp Hematol 33(4):395–402. doi:10.1016/j.exphem.2004.12.010
Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M (1994) E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79(5):885–892
Banerjee A, Northrup D, Boukarabila H, Jacobsen SE, Allman D (2013) Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity 38(5):930–942. doi:10.1016/j.immuni.2013.01.014
Basso K, Dalla-Favera R (2012) Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 247(1):172–183. doi:10.1111/j.1600-065X.2012.01112.x
Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R (2005) E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J Exp Med 202(12):1669–1677. doi:10.1084/jem.20051190
Bouamar H, Abbas S, Lin AP, Wang L, Jiang D, Holder KN, Kinney MC, Hunicke-Smith S, Aguiar RC (2013) A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood 122(5):726–733. doi:10.1182/blood-2013-04-495804
Brass AL, Zhu AQ, Singh H (1999) Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J 18(4):977–991. doi:10.1093/emboj/18.4.977
Calnan DR, Brunet A (2008) The FoxO code. Oncogene 27(16):2276–2288. doi:10.1038/onc.2008.21
Carotta S, Dakic A, D’Amico A, Pang SH, Greig KT, Nutt SL, Wu L (2010) The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32(5):628–641. doi:10.1016/j.immuni.2010.05.005
Carpinelli MR, Hilton DJ, Metcalf D, Antonchuk JL, Hyland CD, Mifsud SL, Di Rago L, Hilton AA, Willson TA, Roberts AW, Ramsay RG, Nicola NA, Alexander WS (2004) Suppressor screen in Mpl−/− mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci USA 101(17):6553–6558. doi:10.1073/pnas.0401496101
Clark MR (2011) Flippin’ lipids. Nat Immunol 12(5):373–375. doi:10.1038/ni.2024
Clark MR, Mandal M, Ochiai K, Singh H (2014) Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 14(2):69–80. doi:10.1038/nri3570
Clayton E, Bardi G, Bell SE, Chantry D, Downes CP, Gray A, Humphries LA, Rawlings D, Reynolds H, Vigorito E, Turner M (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196(6):753–763
Cobaleda C, Schebesta A, Delogu A, Busslinger M (2007) Pax5: the guardian of B cell identity and function. Nat Immunol 8(5):463–470. doi:10.1038/ni1454
Cooper AB, Sawai CM, Sicinska E, Powers SE, Sicinski P, Clark MR, Aifantis I (2006) A unique function for cyclin D3 in early B cell development. Nat Immunol 7(5):489–497. doi:10.1038/ni1324
Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL (2005) PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med 201(9):1487–1502. doi:10.1084/jem.20050075
Dakic A, Wu L, Nutt SL (2007) Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 28(3):108–114. doi:10.1016/j.it.2007.01.006
DeKoter RP, Lee HJ, Singh H (2002) PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16(2):297–309
DeKoter RP, Singh H (2000) Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288(5470):1439–1441
Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M (2006) Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24(3):269–281. doi:10.1016/j.immuni.2006.01.012
Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, DePinho RA, Rickert RC (2008) Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9(12):1388–1398. doi:10.1038/ni.1667
Dias S, Månsson R, Gurbuxani S, Sigvardsson M, Kee BL (2008) E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29(2):217–227. doi:10.1016/j.immuni.2008.05.015
Dias S, Silva H, Cumano A, Vieira P (2005) Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med 201(6):971–979. doi:10.1084/jem.20042393
Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM, Valls E, Klemm L, Shojaee S, Cerchietti L, Schuh W, Jack HM, Hurtz C, Ramezani-Rad P, Herzog S, Jumaa H, Koeffler HP, de Alboran IM, Melnick AM, Ye BH, Muschen M (2010) BCL6 is critical for the development of a diverse primary B cell repertoire. J Exp Med 207(6):1209–1221. doi:10.1084/jem.20091299
Eisenbeis CF, Singh H, Storb U (1995) Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9(11):1377–1387
Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J (2003) Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 22(17):4478–4488. doi:10.1093/emboj/cdg434
Escalante CR, Brass AL, Pongubala JM, Shatova E, Shen L, Singh H, Aggarwal AK (2002) Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell 10(5):1097–1105
Fahl SP, Crittenden RB, Allman D, Bender TP (2009) c-Myb is required for pro-B cell differentiation. J Immunol 183(9):5582–5592. doi:10.4049/jimmunol.0901187
Ferreiros-Vidal I, Carroll T, Taylor B, Terry A, Liang Z, Bruno L, Dharmalingam G, Khadayate S, Cobb BS, Smale ST, Spivakov M, Srivastava P, Petretto E, Fisher AG, Merkenschlager M (2013) Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood 121(10):1769–1782. doi:10.1182/blood-2012-08-450114
Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW, Cantley LC (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283(5400):393–397
Fuxa M, Busslinger M (2007) Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J Immunol 178(12):8222–8228
Goetz CA, Harmon IR, O’Neil JJ, Burchill MA, Farrar MA (2004) STAT5 activation underlies IL7 receptor-dependent B cell development. Journal of immunology (Baltimore, Md: 1950) 172(8):4770–4778
Gounari F, Aifantis I, Martin C, Fehling H-J, Hoeflinger S, Leder P, von Boehmer H, Reizis B (2002) Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat Immunol 3(5):489–496. doi:10.1038/ni778
Grawunder U, Leu TM, Schatz DG, Werner A, Rolink AG, Melchers F, Winkler TH (1995) Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3(5):601–608
Greig KT, Carotta S, Nutt SL (2008) Critical roles for c-Myb in hematopoietic progenitor cells. Semin Immunol 20(4):247–256. doi:10.1016/j.smim.2008.05.003
Greig KT, de Graaf CA, Murphy JM, Carpinelli MR, Pang SH, Frampton J, Kile BT, Hilton DJ, Nutt SL (2010) Critical roles for c-Myb in lymphoid priming and early B-cell development. Blood 115(14):2796–2805. doi:10.1182/blood-2009-08-239210
Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R, Curley DP, Kutok JL, Akashi K, Williams IR, Speck NA, Gilliland DG (2005) Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106(2):494–504. doi:10.1182/blood-2004-08-3280
Gyory I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E, Grosschedl R (2012) Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev 26(7):668–682. doi:10.1101/gad.187328.112
Heizmann B, Kastner P, Chan S (2013) Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals. J Exp Med 210(13):2823–2832. doi:10.1084/jem.20131735
Heltemes-Harris LM, Willette MJ, Ramsey LB, Qiu YH, Neeley ES, Zhang N, Thomas DA, Koeuth T, Baechler EC, Kornblau SM, Farrar MA (2011) Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. J Exp Med 208(6):1135–1149. doi:10.1084/jem.20101947
Herzog S, Reth M, Jumaa H (2009) Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 9(3):195–205. doi:10.1038/nri2491
Holmes ML, Carotta S, Corcoran LM, Nutt SL (2006) Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev 20(8):933–938. doi:10.1101/gad.1396206
Holmes ML, Pridans C, Nutt SL (2008) The regulation of the B-cell gene expression programme by Pax5. Immunol Cell Biol 86(1):47–53. doi:10.1038/sj.icb.7100134
Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A (2006) Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 7(8):819–826. doi:10.1038/ni1358
Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW (2002) Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17(2):117–130
Ikawa T, Kawamoto H, Wright LYT, Murre C (2004) Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20(3):349–360
Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, Karsunky H, Plevritis SK, Dill DL, Weissman IL (2009) Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev 23(20):2376–2381. doi:10.1101/gad.1836009
Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram T, Fenyus ML, Elf S, Chan S, Kastner P, Huettner CS, Murray R, Tenen DG, Akashi K (2005) Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106(5):1590–1600. doi:10.1182/blood-2005-03-0860
Jo SH, Schatz JH, Acquaviva J, Singh H, Ren R (2010) Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood 116(15):2759–2767. doi:10.1182/blood-2009-07-234559
John LB, Ward AC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48(9–10):1272–1278. doi:10.1016/j.molimm.2011.03.006
Johnson K, Hashimshony T, Sawai CM, Pongubala JM, Skok JA, Aifantis I, Singh H (2008) Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28(3):335–345. doi:10.1016/j.immuni.2007.12.019
Joshi I, Yoshida T, Jena N, Qi X, Zhang J, Van Etten RA, Georgopoulos K (2014) Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia. Nat Immunol. doi:10.1038/ni.2821
Jou S-T, Carpino N, Takahashi Y, Piekorz R, Chao J-R, Carpino N, Wang D, Ihle JN (2002) Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22(24):8580–8591
Jumaa H, Bossaller L, Portugal K, Storch B, Lotz M, Flemming A, Schrappe M, Postila V, Riikonen P, Pelkonen J, Niemeyer CM, Reth M (2003) Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 423(6938):452–456. doi:10.1038/nature01608
Karasuyama H, Kudo A, Melchers F (1990) The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain. J Exp Med 172(3):969–972
Karasuyama H, Rolink A, Shinkai Y, Young F, Alt FW, Melchers F (1994) The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 77(1):133–143
Karnowski A, Cao C, Matthias G, Carotta S, Corcoran LM, Martensson IL, Skok JA, Matthias P (2008) Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1. PLoS ONE 3(10):e3568. doi:10.1371/journal.pone.0003568
Karsunky H, Inlay MA, Serwold T, Bhattacharya D, Weissman IL (2008) Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood 111(12):5562–5570. doi:10.1182/blood-2007-11-126219
Kirstetter P, Thomas M, Dierich A, Kastner P, Chan S (2002) Ikaros is critical for B cell differentiation and function. Eur J Immunol 32(3):720–730. doi:10.1002/1521-4141(200203)32:3<720:AID-IMMU720>3.0.CO;2-P
Kitamura D, Kudo A, Schaal S, Müller W, Melchers F, Rajewsky K (1992) A critical role of lambda 5 protein in B cell development. Cell 69(5):823–831
Kitamura D, Roes J, Kühn R, Rajewsky K (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350(6317):423–426. doi:10.1038/350423a0
Kondo M, Weissman IL, Akashi K (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91(5):661–672
Kosan C, Saba I, Godmann M, Herold S, Herkert B, Eilers M, Moroy T (2010) Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 33(6):917–928. doi:10.1016/j.immuni.2010.11.028
Kueh HY, Champhekar A, Nutt SL, Elowitz MB, Rothenberg EV (2013) Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science 341(6146):670–673. doi:10.1126/science.1240831
Kuiper RP, Schoenmakers EF, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, van Leeuwen FN, Hoogerbrugge PM (2007) High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21(6):1258–1266. doi:10.1038/sj.leu.2404691
Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B, Sonneveld E, van Dongen JJ, Veerman AJ, van Leeuwen FN, van Kessel AG, Hoogerbrugge PM (2010) IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24(7):1258–1264. doi:10.1038/leu.2010.87
Kwon K, Hutter C, Sun Q, Bilic I, Cobaleda C, Malin S, Busslinger M (2008) Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28(6):751–762. doi:10.1016/j.immuni.2008.04.014
Lazorchak AS, Schlissel MS, Zhuang Y (2006) E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells. Mol Cell Biol 26(3):810–821. doi:10.1128/MCB.26.3.810-821.2006
Li YS, Hayakawa K, Hardy RR (1993) The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med 178(3):951–960
Li YS, Wasserman R, Hayakawa K, Hardy RR (1996) Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5(6):527–535
Lin H, Grosschedl R (1995) Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376(6537):263–267. doi:10.1038/376263a0
Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, Ideker T, Glass CK, Murre C (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11(7):635–643. doi:10.1038/ni.1891
Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, Lamers MC, Carsetti R (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190(1):75–89
Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR (2004) Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood 103(7):2522–2529. doi:10.1182/blood-2003-07-2439
Lu R, Medina KL, Lancki DW, Singh H (2003) IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev 17(14):1703–1708. doi:10.1101/gad.1104803
Ma S, Pathak S, Trinh L, Lu R (2008) Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111(3):1396–1403. doi:10.1182/blood-2007-08-110106
Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL, Ikawa T, Murre C, Singh H, Hardy RR, Hagman J (2004) Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 5(10):1069–1077. doi:10.1038/ni1119
Malin S, McManus S, Cobaleda C, Novatchkova M, Delogu A, Bouillet P, Strasser A, Busslinger M (2010) Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 11(2):171–179. doi:10.1038/ni.1827
Mandel EM, Grosschedl R (2010) Transcription control of early B cell differentiation. Curr Opin Immunol 22(2):161–167. doi:10.1016/j.coi.2010.01.010
Mansson R, Zandi S, Anderson K, Martensson I-L, Jacobsen SEW, Bryder D, Sigvardsson M (2008) B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. Blood 112(4):1048–1055. doi:10.1182/blood-2007-11-125385
Mansson R, Zandi S, Welinder E, Tsapogas P, Sakaguchi N, Bryder D, Sigvardsson M (2010) Single-cell analysis of the common lymphoid progenitor compartment reveals functional and molecular heterogeneity. Blood 115(13):2601–2609. doi:10.1182/blood-2009-08-236398
McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, Jaritz M, Tagoh H, Busslinger M (2011) The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J 30(12):2388–2404. doi:10.1038/emboj.2011.140
Medina KL, Pongubala JM, Reddy KL, Lancki DW, Dekoter R, Kieslinger M, Grosschedl R, Singh H (2004) Assembling a gene regulatory network for specification of the B cell fate. Dev Cell 7(4):607–617. doi:10.1016/j.devcel.2004.08.006
Mercer EM, Lin YC, Benner C, Jhunjhunwala S, Dutkowski J, Flores M, Sigvardsson M, Ideker T, Glass CK, Murre C (2011) Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35(3):413–425. doi:10.1016/j.immuni.2011.06.013
Merup M, Moreno TC, Heyman M, Ronnberg K, Grander D, Detlofsson R, Rasool O, Liu Y, Soderhall S, Juliusson G, Gahrton G, Einhorn S (1998) 6q deletions in acute lymphoblastic leukemia and non-Hodgkin’s lymphomas. Blood 91(9):3397–3400
Mikkola I, Heavey B, Horcher M, Busslinger M (2002) Reversion of B cell commitment upon loss of Pax5 expression. Science 297(5578):110–113. doi:10.1126/science.1067518
Mittrücker HW, Matsuyama T, Grossman A, Kündig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275(5299):540–543
Moroy T, Khandanpour C (2011) Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation. Semin Immunol 23(5):368–378. doi:10.1016/j.smim.2011.08.006
Moroy T, Saba I, Kosan C (2011) The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference. Semin Immunol 23(5):379–387. doi:10.1016/j.smim.2011.09.001
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446(7137):758–764. doi:10.1038/nature05690
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz MJ, Pui CH, Smith M, Hunger SP, Willman CL, Downing JR, Children’s Oncology G (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360(5):470–480. doi:10.1056/NEJMoa0808253
Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, Buetow KH, Pui CH, Baker SD, Brindle PK, Downing JR (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471(7337):235–239. doi:10.1038/nature09727
Murre C (2007) Regulation and function of the E2A proteins in B cell development. Adv Exp Med Biol 596:1–7. doi:10.1007/0-387-46530-8_1
Muto A, Tashiro S, Nakajima O, Hoshino H, Takahashi S, Sakoda E, Ikebe D, Yamamoto M, Igarashi K (2004) The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429(6991):566–571. doi:10.1038/nature02596
Nahar R, Ramezani-Rad P, Mossner M, Duy C, Cerchietti L, Geng H, Dovat S, Jumaa H, Ye BH, Melnick A, Muschen M (2011) Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood 118(15):4174–4178. doi:10.1182/blood-2011-01-331181
Nechanitzky R, Akbas D, Scherer S, Gyory I, Hoyler T, Ramamoorthy S, Diefenbach A, Grosschedl R (2013) Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells. Nat Immunol 14(8):867–875. doi:10.1038/ni.2641
Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Gunther T, Alawi M, Bergholz U, Muller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C (2013a) Runx1 is essential at two stages of early murine B-cell development. Blood 122(3):413–423. doi:10.1182/blood-2013-01-480244
Niebuhr DW, Gubata ME, Oetting AA, Weber NS, Feng X, Cowan DN (2013b) Personality Assessment Questionnaire as a pre-accession screen for risk of mental disorders and early attrition in U. S. Army recruits. Psychol Serv 10(4):378–385. doi:10.1037/a0032783
Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401(6753):556–562. doi:10.1038/44076
Nutt SL, Kee BL (2007) The transcriptional regulation of B cell lineage commitment. Immunity 26(6):715–725. doi:10.1016/j.immuni.2007.05.010
Nutt SL, Metcalf D, D’Amico A, Polli M, Wu L (2005) Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med 201(2):221–231. doi:10.1084/jem.20041535
Nutt SL, Urbánek P, Rolink A, Busslinger M (1997) Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 11(4):476–491
Ochiai K, Maienschein-Cline M, Mandal M, Triggs JR, Bertolino E, Sciammas R, Dinner AR, Clark MR, Singh H (2012) A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol 13(3):300–307. doi:10.1038/ni.2210
Ochiai K, Maienschein-Cline M, Simonetti G, Chen J, Rosenthal R, Brink R, Chong AS, Klein U, Dinner AR, Singh H, Sciammas R (2013) Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38(5):918–929. doi:10.1016/j.immuni.2013.04.009
Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJH, Vanhaesebroeck B (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297(5583):1031–1034. doi:10.1126/science.1073560
Pang SHM, Nutt SL (2011) B cells need their flip-flops. Immunol Cell Biol 89(7):751–752. doi:10.1038/icb.2011.48
Parker H, An Q, Barber K, Case M, Davies T, Konn Z, Stewart A, Wright S, Griffiths M, Ross FM, Moorman AV, Hall AG, Irving JA, Harrison CJ, Strefford JC (2008) The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes Chromosomes Cancer 47(12):1118–1125. doi:10.1002/gcc.20613
Pathak S, Ma S, Trinh L, Lu R (2008) A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol 28(8):2815–2824. doi:10.1128/MCB.01946-07
Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL (1994) Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180(5):1955–1960
Polli M, Dakic A, Light A, Wu L, Tarlinton DM, Nutt SL (2005) The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 106(6):2083–2090. doi:10.1182/blood-2005-01-0283
Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML (1992) PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3’ enhancer activity. Mol Cell Biol 12(1):368–378
Pongubala JMR, Northrup DL, Lancki DW, Medina KL, Treiber T, Bertolino E, Thomas M, Grosschedl R, Allman D, Singh H (2008) Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol 9(2):203–215. doi:10.1038/ni1555
Pridans C, Holmes ML, Polli M, Wettenhall JM, Dakic A, Corcoran LM, Smyth GK, Nutt SL (2008) Identification of Pax5 target genes in early B cell differentiation. J Immunol 180(3):1719–1728
Ramadani F, Bolland DJ, Garcon F, Emery JL, Vanhaesebroeck B, Corcoran AE, Okkenhaug K (2010) The PI3Â K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Science signaling 3(134):ra60. doi:10.1126/scisignal.2001104
Revilla IDR, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, Smeenk L, Trupke J, Sommer A, Jaritz M, Busslinger M (2012) The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J 31(14):3130–3146. doi:10.1038/emboj.2012.155
Reynaud D, Demarco IA, Reddy KL, Schjerven H, Bertolino E, Chen Z, Smale ST, Winandy S, Singh H (2008) Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol 9(8):927–936. doi:10.1038/ni.1626
Roessler S, Gyory I, Imhof S, Spivakov M, Williams RR, Busslinger M, Fisher AG, Grosschedl R (2007) Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol Cell Biol 27(2):579–594. doi:10.1128/MCB.01192-06
Rolink A, Grawunder U, Winkler TH, Karasuyama H, Melchers F (1994) IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol 6(8):1257–1264
Rolink AG, Nutt SL, Melchers F, Busslinger M (1999) Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401(6753):603–606. doi:10.1038/44164
Rumfelt LL, Zhou Y, Rowley BM, Shinton SA, Hardy RR (2006) Lineage specification and plasticity in CD19- early B cell precursors. J Exp Med 203(3):675–687. doi:10.1084/jem.20052444
Sandberg ML, Sutton SE, Pletcher MT, Wiltshire T, Tarantino LM, Hogenesch JB, Cooke MP (2005) c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 8(2):153–166. doi:10.1016/j.devcel.2004.12.015
Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger GA, Busslinger M (2007) Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity 27(1):49–63. doi:10.1016/j.immuni.2007.05.019
Schulz D, Vassen L, Chow KT, McWhirter SM, Amin RH, Moroy T, Schlissel MS (2012) Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1. J Exp Med 209(1):187–199. doi:10.1084/jem.20110645
Schwickert TA, Tagoh H, Gultekin S, Dakic A, Axelsson E, Minnich M, Ebert A, Werner B, Roth M, Cimmino L, Dickins RA, Zuber J, Jaritz M, Busslinger M (2014) Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol. doi:10.1038/ni.2828
Sciammas R, Li Y, Warmflash A, Song Y, Dinner AR, Singh H (2011) An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. Mol Syst Biol 7:495. doi:10.1038/msb.2011.25
Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25(2):225–236. doi:10.1016/j.immuni.2006.07.009
Scott EW, Simon MC, Anastasi J, Singh H (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265(5178):1573–1577
Seet CS, Brumbaugh RL, Kee BL (2004) Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J Exp Med 199(12):1689–1700. doi:10.1084/jem.20032202
Seo W, Ikawa T, Kawamoto H, Taniuchi I (2012) Runx1-Cbfbeta facilitates early B lymphocyte development by regulating expression of Ebf1. J Exp Med 209(7):1255–1262. doi:10.1084/jem.20112745
Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM (2008) IRF4 addiction in multiple myeloma. Nature 454(7201):226–231. doi:10.1038/nature07064
Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, Ma J, Chen SC, Song G, Cheng J, Meyers P, Bhojwani D, Jhanwar S, Maslak P, Fleisher M, Littman J, Offit L, Rau-Murthy R, Fleischut MH, Corines M, Murali R, Gao X, Manschreck C, Kitzing T, Murty VV, Raimondi SC, Kuiper RP, Simons A, Schiffman JD, Onel K, Plon SE, Wheeler DA, Ritter D, Ziegler DS, Tucker K, Sutton R, Chenevix-Trench G, Li J, Huntsman DG, Hansford S, Senz J, Walsh T, Lee M, Hahn CN, Roberts KG, King MC, Lo SM, Levine RL, Viale A, Socci ND, Nathanson KL, Scott HS, Daly M, Lipkin SM, Lowe SW, Downing JR, Altshuler D, Sandlund JT, Horwitz MS, Mullighan CG, Offit K (2013) A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 45(10):1226–1231. doi:10.1038/ng.2754
Shukla V, Ma S, Hardy RR, Joshi SS, Lu R (2013) A role for IRF4 in the development of CLL. Blood 122(16):2848–2855. doi:10.1182/blood-2013-03-492769
Siggs OM, Arnold CN, Huber C, Pirie E, Xia Y, Lin P, Nemazee D, Beutler B (2011) The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. Nat Immunol 12(5):434–440. doi:10.1038/ni.2012
Singh H, Medina KL, Pongubala JM (2005) Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci USA 102(14):4949–4953. doi:10.1073/pnas.0500480102
Singh H, Pongubala JM, Medina KL (2007) Gene regulatory networks that orchestrate the development of B lymphocyte precursors. Adv Exp Med Biol 596:57–62. doi:10.1007/0-387-46530-8_5
Sokalski KM, Li SK, Welch I, Cadieux-Pitre HA, Gruca MR, DeKoter RP (2011) Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia. Blood 118(10):2801–2808. doi:10.1182/blood-2011-02-335539
Souabni A, Cobaleda C, Schebesta M, Busslinger M (2002) Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17(6):781–793
Speck NA, Gilliland DG (2002) Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2(7):502–513. doi:10.1038/nrc840
Spooner CJ, Cheng JX, Pujadas E, Laslo P, Singh H (2009) A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 31(4):576–586. doi:10.1016/j.immuni.2009.07.011
Su GH, Chen HM, Muthusamy N, Garrett-Sinha LA, Baunoch D, Tenen DG, Simon MC (1997) Defective B cell receptor-mediated responses in mice lacking the Ets protein Spi-B. EMBO J 16(23):7118–7129. doi:10.1093/emboj/16.23.7118
Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283(5400):390–392
Swaminathan S, Duy C, Muschen M (2013a) BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint. Trends Immunol. doi:10.1016/j.it.2013.11.002
Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah MF, Nowak D, Thoennissen GB, Rand V, Graeber TG, Koeffler HP, Carroll WL, Willman CL, Hall AG, Igarashi K, Melnick A, Muschen M (2013b) BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. Nat Med 19(8):1014–1022. doi:10.1038/nm.3247
Tagoh H, Ingram R, Wilson N, Salvagiotto G, Warren AJ, Clarke D, Busslinger M, Bonifer C (2006) The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J 25(5):1070–1080. doi:10.1038/sj.emboj.7600997
ten Boekel E, Melchers F, Rolink A (1995) The status of Ig loci rearrangements in single cells from different stages of B cell development. Int Immunol 7(6):1013–1019
Thompson EC, Cobb BS, Sabbattini P, Meixlsperger S, Parelho V, Liberg D, Taylor B, Dillon N, Georgopoulos K, Jumaa H, Smale ST, Fisher AG, Merkenschlager M (2007) Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26(3):335–344. doi:10.1016/j.immuni.2007.02.010
Timblin GA, Schlissel MS (2013) Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development. J Immunol 191(9):4676–4687. doi:10.4049/jimmunol.1301675
Treiber T, Mandel EM, Pott S, Gyory I, Firner S, Liu ET, Grosschedl R (2010) Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity 32(5):714–725. doi:10.1016/j.immuni.2010.04.013
Trinh DL, Scott DW, Morin RD, Mendez-Lago M, An J, Jones SJ, Mungall AJ, Zhao Y, Schein J, Steidl C, Connors JM, Gascoyne RD, Marra MA (2013) Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood 121(18):3666–3674. doi:10.1182/blood-2013-01-479865
Vassen L, Okayama T, Moroy T (2007) Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1. Blood 109(6):2356–2364. doi:10.1182/blood-2006-06-030031
Vilagos B, Hoffmann M, Souabni A, Sun Q, Werner B, Medvedovic J, Bilic I, Minnich M, Axelsson E, Jaritz M, Busslinger M (2012) Essential role of EBF1 in the generation and function of distinct mature B cell types. J Exp Med 209(4):775–792. doi:10.1084/jem.20112422
Vosshenrich CA, Cumano A, Muller W, Di Santo JP, Vieira P (2003) Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol 4(8):773–779. doi:10.1038/ni956
Wang H, Lee CH, Qi C, Tailor P, Feng J, Abbasi S, Atsumi T, Morse HC 3rd (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112(10):4028–4038. doi:10.1182/blood-2008-01-129049
Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5(6):537–549
Welinder E, Mansson R, Mercer EM, Bryder D, Sigvardsson M, Murre C (2011) The transcription factors E2A and HEB act in concert to induce the expression of FOXO1 in the common lymphoid progenitor. Proc Natl Acad Sci USA 108(42):17402–17407. doi:10.1073/pnas.1111766108
Willis SN, Good-Jacobson KL, Curtis J, Light A, Tellier J, Shi W, Smyth GK, Tarlinton DM, Belz GT, Corcoran LM, Kallies A, Nutt SL (2014) Transcription factor IRF4 regulates germinal center formation through a B-cell intrinsic mechanism. J Immunol (in press)
Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131(1):146–159. doi:10.1016/j.cell.2007.07.021
Xu LS, Sokalski KM, Hotke K, Christie DA, Zarnett O, Piskorz J, Thillainadesan G, Torchia J, DeKoter RP (2012) Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia. J Immunol 189(7):3347–3354. doi:10.4049/jimmunol.1201267
Yabas M, Teh CE, Frankenreiter S, Lal D, Roots CM, Whittle B, Andrews DT, Zhang Y, Teoh NC, Sprent J, Tze LE, Kucharska EM, Kofler J, Farell GC, Bröer S, Goodnow CC, Enders A (2011) ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes. Nat Immunol 12(5):441–449. doi:10.1038/ni.2011
Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD, Li D, Durum SK, Jiang Q, Bhandoola A, Hennighausen L, O’Shea JJ (2006) Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci USA 103(4):1000–1005. doi:10.1073/pnas.0507350103
Ye M, Ermakova O, Graf T (2005) PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J Exp Med 202(10):1411–1422. doi:10.1084/jem.20051089
Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K (2006) Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 7(4):382–391. doi:10.1038/ni1314
Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M, Buetow KH, Carroll WL, Chen IM, Devidas M, Gerhard DS, Loh ML, Reaman GH, Relling MV, Camitta BM, Bowman WP, Smith MA, Willman CL, Downing JR, Hunger SP (2011) Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood 118(11):3080–3087. doi:10.1182/blood-2011-03-341412
Zhang Z, Cotta CV, Stephan RP, deGuzman CG, Klug CA (2003) Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J 22(18):4759–4769. doi:10.1093/emboj/cdg464
Zhuang Y, Soriano P, Weintraub H (1994) The helix-loop-helix gene E2A is required for B cell formation. Cell 79(5):875–884
Acknowledgments
This work was supported by a National Health and Medical Research Council (NHRMC) of Australia program grant (575500 to S.L.N). S.H.M.P. was supported by the Leukaemia Foundation of Australia, S.L.N. by an Australian Research Council Future Fellowship and S.C. by an NHMRC Career Development Fellowship. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pang, S.H.M., Carotta, S., Nutt, S.L. (2014). Transcriptional Control of Pre-B Cell Development and Leukemia Prevention. In: Ellmeier, W., Taniuchi, I. (eds) Transcriptional Control of Lineage Differentiation in Immune Cells. Current Topics in Microbiology and Immunology, vol 381. Springer, Cham. https://doi.org/10.1007/82_2014_377
Download citation
DOI: https://doi.org/10.1007/82_2014_377
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07394-1
Online ISBN: 978-3-319-07395-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)